Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Cosmos Health (COSM) EPS (Weighted Average and Diluted) (2016 - 2025)

Cosmos Health (COSM) has disclosed EPS (Weighted Average and Diluted) for 13 consecutive years, with -$0.19 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, EPS (Weighted Average and Diluted) rose 57.78% year-over-year to -$0.19, compared with a TTM value of -$0.78 through Sep 2025, up 68.29%, and an annual FY2024 reading of -$1.17, up 45.58% over the prior year.
  • EPS (Weighted Average and Diluted) was -$0.19 for Q3 2025 at Cosmos Health, down from -$0.1 in the prior quarter.
  • Across five years, EPS (Weighted Average and Diluted) topped out at -$0.03 in Q1 2025 and bottomed at -$31.99 in Q4 2022.
  • Average EPS (Weighted Average and Diluted) over 5 years is -$3.69, with a median of -$0.19 recorded in 2025.
  • The sharpest move saw EPS (Weighted Average and Diluted) plummeted 38800.0% in 2021, then surged 99.49% in 2023.
  • Year by year, EPS (Weighted Average and Diluted) stood at -$23.34 in 2021, then tumbled by 37.06% to -$31.99 in 2022, then soared by 94.53% to -$1.75 in 2023, then soared by 73.71% to -$0.46 in 2024, then soared by 58.7% to -$0.19 in 2025.
  • Business Quant data shows EPS (Weighted Average and Diluted) for COSM at -$0.19 in Q3 2025, -$0.1 in Q2 2025, and -$0.03 in Q1 2025.